Drugs / Gerilimzumab
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02795299 Comparator | Jan 2018 → May 2019 | rheumatoid arthritis | Bird Rock Bio, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gerilimzumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02795299 ↗ |
| Route | Subcutaneous | “Gerilimzumab and placebo will be administered as SC injections Q8W” NCT02795299 ↗ |